Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
35
Number of overlapping holdings
10.3%
% of FHLC's 368 holdings also in IHE
100.0%
% of IHE's 36 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.6% | 21.8% | 11.6% |
|
JOHNSON & JOHNSON | 5.7% | 23.5% | 5.7% |
|
MERCK & CO. INC. | 5.3% | 4.3% | 4.3% |
|
PFIZER INC | 2.5% | 4.8% | 2.5% |
|
BRISTOL-MYERS SQUIBB CO | 1.4% | 4.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to IHE
|
UNITEDHEALTH GROUP INC | 7.5% |
|
ABBVIE INC | 4.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
ABBOTT LABORATORIES | 2.9% |
|
DANAHER CORP | 2.9% |
|
AMGEN INC | 2.6% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
ELEVANCE HEALTH INC | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
STRYKER CORP | 1.9% |
FHLC Underweight Relative to IHE
|
JOHNSON & JOHNSON | -17.8% |
|
ELI LILLY & CO | -10.3% |
|
VIATRIS, INC. | -4.7% |
|
ROYALTY PHARMA PLC CLASS A | -4.2% |
|
CATALENT INC | -4.0% |
|
ZOETIS INC | -3.2% |
|
BRISTOL-MYERS SQUIBB CO | -3.1% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
 |
JAZZ PHARMACEUTICALS PLC | -2.6% |
|
ELANCO ANIMAL HEALTH, INC. | -2.4% |